Innovative Sciences News Today

Is valued at almost 8 billion but the question everyone is asking is it worth it. Well talk to the ceo after the opening trade. And facebook is jumping into a new arena, Virtual Reality, they are buying oculusvr in a deal worth about 2 billion. So what can virtual do for social . Well try to find out. Blackrock Ceo Larry Fink sounding the alarm about the recent popularity of dividends and buybacks. In a letter this morning well tell you exactly what he had to say. First up, though, King Digital ...

/PRNewswire/ -- Kognito, an experiential learning company, announced the release of Postvention as Prevention: Coping with Loss at School, a research article...

/PRNewswire/ -- Kognito, an experiential learning company, announced the release of Postvention as Prevention: Coping with Loss at School, a research article...

"If we work together, we have a real chance of being a leader. If you are a leader in this industry, it could mean many jobs and millions of dollars of economic output. It could be one of the more significant economic development activities in recent history in Rochester."

Virtual event on Tuesday, May 3rd at 10:00 AM ET An overview of unmet medical needs and therapeutic opportunities in schizophrenia and major...

/PRNewswire/ -- Apex Innovative Sciences ("Apex" or the "Company"), a leading provider of clinical development and trial site services, is pleased to announce...

Researchers have come up with a new technology to deliver augmented and virtual reality glasses that don’t look like “bug eyes.” “Image” is everything in the $20 billion market for AR/VR glasses. Consumers are looking for glasses that are compact and easy to wear, delivering high-quality imagery with socially acceptable optics. In a new paper in Science Advances, researchers describe imprinting freeform optics with a nanophotonic optical element called “a metasurface.” The metasu...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ... BioXcel TherapeuticsFebruary 12, 2021 GMT NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscienc...